Table 1 Summary of strains used in the... | American Society of Hematology

Table 1

Summary of strains used in the research

Figure no.	RBC donor	Recipient	BMT donor	Main conclusion
2A-B
Strain	BALB.B	B6	BALB.B	Exposure to mHAs in leukoreduced RBC units induce BMT rejection.
MHC	H-2^b	H-2^b	H-2^b
mHA	BALB*	B6	BALB*
2C-D
Strain	BALB/c	B6	BALB.B	The indirect presentation pathway is sufficient to induce BMT rejection.
MHC	H-2^d*	H-2^b	H-2^b
mHA	BALB*	B6	BALB*
2E-G
Strain	B6.H2^d*	B6	BALB.B	Immunization against H-2^d is not responsible for mHA-mismatched BMT rejection.
MHC	H-2^d*	H-2^b	H-2^b
mHA	B6	B6	BALB*
3
Strain	Male B10.BR	Female B6	Male B6	Removal of leukocyte-associated mHAs by filtration leukoreduction is sufficient to prevent BMT rejection.
MHC	H-2^k*	H-2^b	H-2^b
mHA	HY*	—	HY*

Figure no.	RBC donor	Recipient	BMT donor	Main conclusion
2A-B
Strain	BALB.B	B6	BALB.B	Exposure to mHAs in leukoreduced RBC units induce BMT rejection.
MHC	H-2^b	H-2^b	H-2^b
mHA	BALB*	B6	BALB*
2C-D
Strain	BALB/c	B6	BALB.B	The indirect presentation pathway is sufficient to induce BMT rejection.
MHC	H-2^d*	H-2^b	H-2^b
mHA	BALB*	B6	BALB*
2E-G
Strain	B6.H2^d*	B6	BALB.B	Immunization against H-2^d is not responsible for mHA-mismatched BMT rejection.
MHC	H-2^d*	H-2^b	H-2^b
mHA	B6	B6	BALB*
3
Strain	Male B10.BR	Female B6	Male B6	Removal of leukocyte-associated mHAs by filtration leukoreduction is sufficient to prevent BMT rejection.
MHC	H-2^k*	H-2^b	H-2^b
mHA	HY*	—	HY*

— indicates not applicable.

MHC and mHA mismatches to the recipient.